Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03639246 |
Recruitment Status :
Completed
First Posted : August 21, 2018
Last Update Posted : February 13, 2023
|
Sponsor:
Aravive, Inc.
Information provided by (Responsible Party):
Aravive, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | January 8, 2021 |
Actual Study Completion Date : | December 30, 2022 |